339 related articles for article (PubMed ID: 29141062)
1. Management of Severe Acne Vulgaris With Topical Therapy.
Stein Gold L; Baldwin HE; Lin T
J Drugs Dermatol; 2017 Nov; 16(11):1134-1138. PubMed ID: 29141062
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and tolerability of a fixed combination of clindamycin phosphate (1.2%) and low concentration benzoyl peroxide (2.5%) aqueous gel in moderate or severe acne subpopulations.
Webster G; Rich P; Gold MH; Mraz S; Calvarese B; Chen D
J Drugs Dermatol; 2009 Aug; 8(8):736-43. PubMed ID: 19663111
[TBL] [Abstract][Full Text] [Related]
3. Adapalene 0.1%/benzoyl peroxide 2.5% gel: a review of its use in the treatment of acne vulgaris in patients aged ≥ 12 years.
Keating GM
Am J Clin Dermatol; 2011 Dec; 12(6):407-20. PubMed ID: 21967116
[TBL] [Abstract][Full Text] [Related]
4. A phase IV, open-label study evaluating the use of triple-combination therapy with minocycline HCl extended-release tablets, a topical antibiotic/retinoid preparation and benzoyl peroxide in patients with moderate to severe acne vulgaris.
Zaenglein AL; Shamban A; Webster G; Del Rosso J; Dover JS; Swinyer L; Stein L; Lin X; Draelos Z; Gold M; Thiboutot D
J Drugs Dermatol; 2013 Jun; 12(6):619-25. PubMed ID: 23839176
[TBL] [Abstract][Full Text] [Related]
5. Fixed Combination of Clindamycin Phosphate 1.2% and Benzoyl Peroxide 3.75% Aqueous Gel: Long-Term Use in Adult Females With Moderate Acne Vulgaris.
Kircik LH
J Drugs Dermatol; 2017 Jun; 16(6):543-546. PubMed ID: 28686771
[TBL] [Abstract][Full Text] [Related]
6. Clindamycin phosphate 1.2%/benzoyl peroxide 3% fixed-dose combination gel versus topical combination therapy of adapalene 0.1% gel and clindamycin phosphate 1.2% gel in the treatment of acne vulgaris in Japanese patients: A multicenter, randomized, investigator-blind, parallel-group study.
Hayashi N; Kurokawa I; Siakpere O; Endo A; Hatanaka T; Yamada M; Kawashima M
J Dermatol; 2018 Aug; 45(8):951-962. PubMed ID: 29905384
[TBL] [Abstract][Full Text] [Related]
7. Treatment of Moderate Acne Vulgaris in Fitzpatrick Skin Type V or VI: Efficacy and Tolerability of Fixed Combination Clindamycin Phosphate 1.2%/Benzoyl Peroxide 3.75% Gel.
Amar L; Kircik LH
J Drugs Dermatol; 2018 Oct; 17(10):1107-1112. PubMed ID: 30365592
[TBL] [Abstract][Full Text] [Related]
8. Management of comedonal acne vulgaris with fixed-combination topical therapy.
Gold MH; Baldwin H; Lin T
J Cosmet Dermatol; 2018 Apr; 17(2):227-231. PubMed ID: 29380941
[TBL] [Abstract][Full Text] [Related]
9. Benzoyl peroxide: enhancing antibiotic efficacy in acne management.
Dutil M
Skin Therapy Lett; 2010; 15(10):5-7. PubMed ID: 21076800
[TBL] [Abstract][Full Text] [Related]
10. Treatment of moderate to severe acne vulgaris in a Hispanic population: a post-hoc analysis of efficacy and tolerability of clindamycin phosphate 1.2%/benzoyl peroxide 2.5% gel.
Cook-Bolden FE
J Drugs Dermatol; 2012 Apr; 11(4):455-9. PubMed ID: 22453581
[TBL] [Abstract][Full Text] [Related]
11. Fitzpatrick skin types and clindamycin phosphate 1.2%/benzoyl peroxide gel: efficacy and tolerability of treatment in moderate to severe acne.
Callender VD
J Drugs Dermatol; 2012 May; 11(5):643-8. PubMed ID: 22527435
[TBL] [Abstract][Full Text] [Related]
12. Combination topical therapy in the treatment of acne.
Del Rosso JQ
Cutis; 2006 Aug; 78(2 Suppl 1):5-12. PubMed ID: 17966494
[TBL] [Abstract][Full Text] [Related]
13. Fixed-combination clindamycin 1%-benzoyl peroxide 5% hydrating gel: a flexible component of acne management.
Tanghetti E
Cutis; 2009 Nov; 84(5 Suppl):18-24. PubMed ID: 19999189
[TBL] [Abstract][Full Text] [Related]
14. Conjoint analysis: a novel, rigorous tool for determining patient preferences for topical antibiotic treatment for acne. A randomised controlled trial.
Kellett N; West F; Finlay AY
Br J Dermatol; 2006 Mar; 154(3):524-32. PubMed ID: 16445786
[TBL] [Abstract][Full Text] [Related]
15. A randomized, single-blind comparison of topical clindamycin + benzoyl peroxide and adapalene in the treatment of mild to moderate facial acne vulgaris.
Langner A; Chu A; Goulden V; Ambroziak M
Br J Dermatol; 2008 Jan; 158(1):122-9. PubMed ID: 18047518
[TBL] [Abstract][Full Text] [Related]
16. Study results of benzoyl peroxide 5%/clindamycin 1% topical gel, adapalene 0.1% gel, and use in combination for acne vulgaris.
Del Rosso JQ
J Drugs Dermatol; 2007 Jun; 6(6):616-22. PubMed ID: 17668527
[TBL] [Abstract][Full Text] [Related]
17. Community-based trial results of combination clindamycin 1%--benzoyl peroxide 5% topical gel plus tretinoin microsphere gel 0.04% or 0.1% or adapalene gel 0.1% in the treatment of moderate to severe acne.
Kircik L
Cutis; 2007 Jul; 80(1 Suppl):10-4. PubMed ID: 17824581
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of tretinoin 0.025%/clindamycin phosphate 1.2% gel in combination with benzoyl peroxide 6% cleansing cloths for the treatment of facial acne vulgaris.
Zeichner JA; Wong V; Linkner RV; Haddican M
J Drugs Dermatol; 2013 Mar; 12(3):277-82. PubMed ID: 23545909
[TBL] [Abstract][Full Text] [Related]
19. Moderate and Severe Inflammatory Acne Vulgaris Effectively Treated with Single-Agent Therapy by a New Fixed-Dose Combination Adapalene 0.3 %/Benzoyl Peroxide 2.5 % Gel: A Randomized, Double-Blind, Parallel-Group, Controlled Study.
Stein Gold L; Weiss J; Rueda MJ; Liu H; Tanghetti E
Am J Clin Dermatol; 2016 Jun; 17(3):293-303. PubMed ID: 26945741
[TBL] [Abstract][Full Text] [Related]
20. Impact of a fixed combination of clindamycin phosphate 1.2%-benzoyl peroxide 2.5% aqueous gel on health-related quality of life in moderate to severe acne vulgaris.
Webster G; Thiboutot DM; Chen DM; Merikle E
Cutis; 2010 Nov; 86(5):263-7. PubMed ID: 21214129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
